Title:
アミノピリジン誘導体およびそれらの選択的ＡＬＫ－２阻害剤としての使用
Document Type and Number:
Japanese Patent JP7253086
Kind Code:
B2
Abstract:
The invention relates to a compound of formula (I) in free form or in pharmaceutically acceptable salt form (I) to pharmaceutical compositions comprising said compound and to the use of said compound in the treatment of heterotopic ossification and fibrodysplasia ossificans progressiva.
Inventors:
Li, Jarian
Arista, Luka
Bab, Three Hari
Bian, Jung Wei
Kui, Kai
Dillon, Michael Patrick
Ratman lane
Elbu, Liao
Riso, Dimitrios
Ramos, Rita
Stefle, Nicholas Johannes
Ulrich, Thomas
Yousselman, Peggy
Wang, Xiao Yang
Waycall, Riladar Marlider
Wailer, Sven
Tsang, Yubo
Butterfly, itzon
Ju, Tin Yin
Arista, Luka
Bab, Three Hari
Bian, Jung Wei
Kui, Kai
Dillon, Michael Patrick
Ratman lane
Elbu, Liao
Riso, Dimitrios
Ramos, Rita
Stefle, Nicholas Johannes
Ulrich, Thomas
Yousselman, Peggy
Wang, Xiao Yang
Waycall, Riladar Marlider
Wailer, Sven
Tsang, Yubo
Butterfly, itzon
Ju, Tin Yin
Application Number:
JP2022025894A
Publication Date:
April 05, 2023
Filing Date:
February 22, 2022
Export Citation:
Assignee:
Novartis Age
International Classes:
C07D405/14; A61K31/4439; A61P19/00; A61P43/00
Domestic Patent References:
| JP2016513661A | ||||
| JP2016510745A | ||||
| JP2015531371A |
Other References:
ACS Chemical Biology,2013年,8,1291-1302
J. Med. Chem.,2014年,57,7900-7915
J. Med. Chem.,2014年,57,7900-7915
Attorney, Agent or Firm:
Michiko Matsutani
Yasushi Ochiai
Yasushi Ochiai